Balancing the toxicity, photothermal effect, and promotion of osteogenesis: Photothermal scaffolds for malignant bone tumor therapy
Source abstract
Abstract
Malignant bone tumors have a high mortality rate and usually occur in adolescents. Postoperative chemotherapy often cannot completely eliminate the tumor tissue, and bone regeneration is complex when bone tumors cause large bone defects. Additionally, the local and systemic toxicity caused by chemotherapy can affect the bone repair and living quality of patient. Therefore, striking a balance between tumor therapy and toxicity is a critical component of anti-tumor research. Photothermal therapy (PTT) has aroused the interest of researchers based on its potential to balance the effects of near-infrared (NIR)-based PTT and toxicity in tumor therapy. The advantages of NIR-triggered PTT include the ability to penetrate tumor tissue, decreased local and systemic damage, and ease of control. This review focuses on applying bone repair biomaterials with photothermal effects in treating large bone defects caused by bone tumors. Specifically, the balance between toxicity, photothermal effect, and promotion of osteogenesis is discussed for different scaffolds. This provides reference information for developing a new generation of biomaterials for treating malignant bone tumors.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Extracellular vesicles in disease · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. New Advances in the Study of Bone Tumors: A Lesson From the 3D Environment10.3389/fphys.2019.00814 ↗
2. Targeting the osteosarcoma cancer stem cell10.1186/1749-799X-5-78 ↗
3. Platinum-carbon-integrated nanozymes for enhanced tumor photodynamic and photothermal therapy10.1039/D0NR02800B ↗
4. Development of MOF "Armor-Plated" phycocyanin and synergistic inhibition of cellular respiration for hypoxic photodynamic therapy in patient-derived xenograft models10.1002/adhm.202001577 ↗
5. Stellate plasmonic exosomes for penetrative targeting tumor NIR-II thermo-radiotherapy10.1021/acsami.0c09969 ↗
6. Recent advances in biomaterial scaffolds for integrative tumor therapy and bone regeneration10.1002/adtp.202000212 ↗
7. Health concerns of various nanoparticles: a review of their in vitro and in vivo toxicity10.3390/nano8090634 ↗
8. Progress of biomaterials for bone tumor therapy
9. An overview of nanotoxicity and nanomedicine research: principles, progress and implications for cancer therapy10.1039/C5TB00956A ↗
10. Impact of silver nanoparticles on human cells: effect of particle size10.3109/17435390.2010.483745 ↗
11. Acute toxicological effects of copper nanoparticles in vivo10.1016/j.toxlet.2005.10.003 ↗
12. Cytotoxicity and genotoxicity of silver nanoparticles in human cells10.1021/nn800596w ↗
13. Pulmonary toxicity and fate of agglomerated 10 and 40 nm aluminum oxyhydroxides following 4-week inhalation exposure of rats: toxic effects are determined by agglomerated, not primary particle size10.1093/toxsci/kfp046 ↗
14. Dextran and polymer polyethylene glycol (PEG) coating reduce both 5 and 30 nm iron oxide nanoparticle cytotoxicity in 2D and 3D cell culture10.3390/ijms13055554 ↗
15. Cationic polymers and their therapeutic potential10.1039/c2cs35094g ↗
16. Trigger responsive polymeric nanocarriers for cancer therapy10.1039/C5BM00002E ↗
17. pH-sensitive nano-systems for drug delivery in cancer therapy, Biotechnol
18. A pH/enzyme-responsive tumor-specific delivery system for doxorubicin10.1016/j.biomaterials.2010.04.049 ↗
19. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin10.1016/j.ijpharm.2014.10.041 ↗
20. Ultrasound-mediated targeted drug delivery with a novel cyclodextrin-based drug carrier by mechanical and thermal mechanisms10.1016/j.jconrel.2013.05.038 ↗
21. Magnetic targeting, tumor microenvironment-responsive intelligent nanocatalysts for enhanced tumor ablation10.1021/acsnano.8b05042 ↗
22. Biocompatible conjugated polymer nanoparticles for efficient photothermal tumor therapy10.1002/smll.201402092 ↗
23. Biomedical and bioactive engineered nanomaterials for targeted tumor photothermal therapy: a review10.1016/j.msec.2019.109891 ↗
24. Shape tunable gallium nanorods mediated tumor enhanced ablation through near-infrared photothermal therapy10.1039/C8NR08296K ↗
25. Polymeric photothermal agents for cancer therapy: recent progress and clinical potential10.1039/D0TB02659J ↗
26. Osteogenesis effects of magnetic nanoparticles modified-porous scaffolds for the reconstruction of bone defect after bone tumor resection10.1093/rb/rbz019 ↗
27. Biomaterials and nanomedicine for bone regeneration: progress and future prospects10.1002/EXP.20210011 ↗
28. A new approach to fabrication of Cs/BG/CNT nanocomposite scaffold towards bone tissue engineering and evaluation of its properties10.1016/j.apsusc.2015.10.048 ↗
29. A biodegradable porous composite scaffold of PGA/beta-TCP for bone tissue engineering10.1016/j.bone.2009.09.031 ↗
30. A biodegradable polymer scaffold for delivery of orthotropic factors10.1016/S0142-9612(00)00122-8 ↗
31. Near-infrared light-triggered drug delivery system based on black phosphorus for in vivo bone regeneration10.1016/j.biomaterials.2018.06.039 ↗
32. Near-infrared light responsive folate targeted gold nanorods for combined photothermal-chemotherapy of osteosarcoma10.1021/acsami.7b03711 ↗
33. 2D MXene-integrated 3D-printing scaffolds for augmented osteosarcoma phototherapy and accelerated tissue reconstruction10.1002/advs.201901511 ↗
34. MXene-based hydrogels endow polyetheretherketone with effective osteogenicity and combined treatment of osteosarcoma and bacterial infection10.1021/acsami.0c14752 ↗
35. MC3T3-E1 pre-osteoblast response and differentiation after graphene oxide nanosheet uptake10.1016/j.colsurfb.2017.06.019 ↗
36. Two-dimensional nanomaterials for photothermal therapy10.1002/anie.201911477 ↗
37. Nanotoxicity: an interplay of oxidative stress, inflammation and cell death10.3390/nano5031163 ↗
38. Interventional photothermal therapy enhanced brachytherapy: a new strategy to fight deep pancreatic cancer10.1002/advs.201801507 ↗
39. Improvement of gold nanorods in photothermal therapy: recent progress and perspective10.3389/fphar.2021.664123 ↗
40. A review of toxicity studies on graphene-based nanomaterials in laboratory animals10.1016/j.yrtph.2017.01.011 ↗
41. Recent advances in nanoparticles mediated photothermal therapy induced tumor regression10.1016/j.ijpharm.2021.120848 ↗
42. Genotoxicity of metal oxide nanomaterials: review of recent data and discussion of possible mechanisms10.1039/C4NR06670G ↗
43. Behavior and toxicity of graphene and its functionalized derivatives in biological systems10.1002/smll.201201417 ↗
44. Nanotoxicity: the toxicity research progress of metal and metal-containing nanoparticles10.2174/138955751507150424104334 ↗
45. Nanoparticles: pharmacological and toxicological significance10.1038/sj.bjp.0707130 ↗
46. Cocrystal strategy toward multifunctional 3D-printing scaffolds enables NIR-activated photonic osteosarcoma hyperthermia and enhanced bone defect regeneration10.1002/adfm.201909938 ↗
47. Mechanisms of nanotoxicity: generation of reactive oxygen species10.1016/j.jfda.2014.01.005 ↗
48. Are nanomaterials a threat to the immune system?10.1080/17435390802604276 ↗
49. Tailoring the component of protein corona via simple chemistry10.1038/s41467-019-12470-5 ↗
50. Protein corona composition and dynamics on carbon nanotubes in blood plasma and cerebrospinal fluid10.1002/anie.202008175 ↗
51. Controlling evolution of protein corona: a prosperous approach to improve chitosan-based nanoparticle biodistribution and half-life10.1038/s41598-020-66572-y ↗
52. Protein corona, understanding the nanoparticle-protein interactions and future perspectives: a critical review10.1016/j.ijbiomac.2020.12.108 ↗
53. Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles10.3109/17435390.2013.773464 ↗
54. Quantum dot-induced epigenetic and genotoxic changes in human breast cancer cells10.1007/s00109-007-0274-2 ↗
55. Structure-dependent mitochondrial dysfunction and hypoxia induced with single-walled carbon nanotubes10.1002/smll.201303342 ↗
56. NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials10.1016/j.biomaterials.2009.04.009 ↗
57. Oxidative stress mediated apoptosis induced by nickel ferrite nanoparticles in cultured A549 cells10.1016/j.tox.2011.02.010 ↗
58. Points of control in inflammation10.1038/nature01320 ↗
59. Simultaneous induction of autophagy and toll-like receptor signaling pathways by graphene oxide10.1016/j.biomaterials.2012.05.064 ↗
60. Toxicity of transition metal oxide nanoparticles: recent insights from in vitro studies10.3390/ma3104842 ↗
61. Nanomaterial cytotoxicity is composition, size, and cell type dependent10.1186/1743-8977-7-22 ↗
62. Lysosomal membrane permeabilization in cell death10.1038/onc.2008.310 ↗
63. Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity10.1186/1743-8977-9-20 ↗
64. Self-eating and self-killing: crosstalk between autophagy and apoptosis10.1038/nrm2239 ↗
65. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts10.1073/pnas.0805135105 ↗
66. Size-dependent cytotoxicity of gold nanoparticles10.1002/smll.200700378 ↗
67. Toxic potential of materials at the nanolevel10.1126/science.1114397 ↗
68. Nanoparticle size and chemical modification play a crucial role in the interaction of nano gold with the brain: extent of accumulation and toxicity10.1039/C9BM02072A ↗
69. The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power10.1016/j.biomaterials.2011.11.064 ↗
70. Comparative protein profile of human hepatoma HepG2 cells treated with graphene and single-walled carbon nanotubes: an iTRAQ-coupled 2D LC–MS/MS proteome analysis10.1016/j.toxlet.2011.09.014 ↗
71. Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells10.1021/nn1007176 ↗
72. The effect of particle design on cellular internalization pathways10.1073/pnas.0801763105 ↗
73. Systematic in vitro nanotoxicity study on anodic alumina nanotubes with engineered aspect ratio: understanding nanotoxicity by a nanomaterial model10.1016/j.biomaterials.2014.12.008 ↗
74. Designed synthesis of CeO2 nanorods and nanowires for studying toxicological effects of high aspect ratio nanomaterials10.1021/nn3012114 ↗
75. MoS(2) exhibits stronger toxicity with increased exfoliation10.1039/C4NR04907A ↗
76. Differences in the toxicological potential of 2D versus aggregated molybdenum disulfide in the lung10.1002/smll.201500906 ↗
77. Minimizing nonspecific phagocytic uptake of biocompatible gold nanoparticles with mixed charged zwitterionic surface modification10.1039/C1JM14178C ↗
78. Surface modification of amorphous nanosilica particles suppresses nanosilica-induced cytotoxicity, ROS generation, and DNA damage in various mammalian cells10.1016/j.bbrc.2012.09.132 ↗
79. The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-beta signaling pathways10.1016/j.biomaterials.2011.09.091 ↗
80. Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts10.1021/am200428v ↗
81. Synthesis and characterization of PEG-functionalized graphene oxide as an effective pH-sensitive drug carrier, Artif. Cells
82. (Intra)cellular stability of inorganic nanoparticles: effects on cytotoxicity, particle functionality, and biomedical applications10.1021/cr400714j ↗
83. A bifunctional scaffold with CuFeSe2 nanocrystals for tumor therapy and bone reconstruction10.1016/j.biomaterials.2017.11.020 ↗
84. Injectable polypeptide-engineered hydrogel depot for amplifying the anti-tumor immune effect induced by chemo-photothermal therapy10.1039/D0TB01370F ↗
85. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains10.1021/bc049951i ↗
86. Size-dependent genotoxicity of graphene nanoplatelets in human stem cells10.1016/j.biomaterials.2012.07.040 ↗
87. Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration10.1016/j.carbon.2010.11.005 ↗
88. Biocompatibility of graphene oxide10.1007/s11671-010-9751-6 ↗
89. Cellular toxicity of carbon-based nanomaterials10.1021/nl060162e ↗
90. The effect of gold nanoparticles on the proliferation and differentiation of murine osteoblast: a study of MC3T3-E1 cells in vitro10.1166/jnn.2014.8717 ↗
91. Nanosurface chemistry and dose govern the bioaccumulation and toxicity of carbon nanotubes, metal nanomaterials and quantum dots in vivo10.1007/s11434-014-0700-0 ↗
92. Oxidative stress-induced DNA damage by particulate air pollution10.1016/j.mrfmmm.2005.06.012 ↗
93. Chitosan coating of copper nanoparticles reduces in vitro toxicity and increases inflammation in the lung10.1088/0957-4484/24/39/395101 ↗
94. In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles10.1016/j.toxrep.2014.11.002 ↗
95. Action of ascorbic acid as a scavenger of active and stable oxygen radicals10.1093/ajcn/54.6.1119s ↗
96. Anti-leukemia activity of PVP-coated silver nanoparticles via generation of reactive oxygen species and release of silver ions10.1016/j.biomaterials.2013.07.015 ↗
97. Beneficial effects of quercetin on oxidative stress in liver and kidney induced by titanium dioxide (TiO2) nanoparticles in rats10.3109/15376516.2015.1006491 ↗
98. Near-infrared light control of bone regeneration with biodegradable photothermal osteoimplant10.1016/j.biomaterials.2018.12.008 ↗
99. Few-layered black phosphorus: from fabrication and customization to biomedical applications10.1002/smll.201702830 ↗
100. Bioengineering applications of black phosphorus and their toxicity assessment10.1039/D1EN00273B ↗